{"title":"镰状细胞性贫血:简介","authors":"Smruti R. Sahoo","doi":"10.4172/2157-7412.20.11.330","DOIUrl":null,"url":null,"abstract":"Sickle cell disorder (SCD), one of the most common genetic disorders worldwide, is now considered as of global importance and medical significance. SCD is a group of red blood cell disorders inherited from a person’s parents where both the parents are carrier for the gene. Sickle cell anemia is an autosomal linked recessive trait, causing severe associated health problems leading to reduced life span. With the help of improved novel strategies and therapies, it is utmost important that the treatment is availed by the less-resourceful, impoverished countries.","PeriodicalId":89584,"journal":{"name":"Journal of genetic syndromes & gene therapy","volume":"68 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sickle Cell Anemia: A Brief Synopsis\",\"authors\":\"Smruti R. Sahoo\",\"doi\":\"10.4172/2157-7412.20.11.330\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sickle cell disorder (SCD), one of the most common genetic disorders worldwide, is now considered as of global importance and medical significance. SCD is a group of red blood cell disorders inherited from a person’s parents where both the parents are carrier for the gene. Sickle cell anemia is an autosomal linked recessive trait, causing severe associated health problems leading to reduced life span. With the help of improved novel strategies and therapies, it is utmost important that the treatment is availed by the less-resourceful, impoverished countries.\",\"PeriodicalId\":89584,\"journal\":{\"name\":\"Journal of genetic syndromes & gene therapy\",\"volume\":\"68 1\",\"pages\":\"1-2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of genetic syndromes & gene therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2157-7412.20.11.330\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of genetic syndromes & gene therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2157-7412.20.11.330","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sickle cell disorder (SCD), one of the most common genetic disorders worldwide, is now considered as of global importance and medical significance. SCD is a group of red blood cell disorders inherited from a person’s parents where both the parents are carrier for the gene. Sickle cell anemia is an autosomal linked recessive trait, causing severe associated health problems leading to reduced life span. With the help of improved novel strategies and therapies, it is utmost important that the treatment is availed by the less-resourceful, impoverished countries.